GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

Source: 
Reuters
snippet: 
  • Regulators narrowed the targeted age group for RSV vaccines
  • Demand for RSV vaccines has fallen by up to two-thirds
  • GSK maintains market lead despite reduced sales